Proximity of first sexual intercourse to menarche and risk of high-grade cervical disease

Journal of Infectious Diseases

Volumn 206, Issue 12, 2012, Pages 1887-1896

  Ruiz, Ángela María ^a   Ruiz, Jaime Enrique ^a,b   Gavilanes, Andrés Velásquez ^a   Eriksson, Tiina ^c   Lehtinen, Matti ^d   Pérez, Gonzalo ^a,e   Sings, Heather L ^e   James, Margaret K ^e   Haupt, Richard M ^e  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b Merck Sharp and Dohme   (Colombia)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT; PLACEBO; VIRUS DNA; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; COLOMBIAN; COLPOSCOPY; CONDOM; CONFIDENCE INTERVAL; ETHNIC GROUP; FEMALE; FINNISH; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; MENARCHE; PAPANICOLAOU TEST; PHASE 3 CLINICAL TRIAL (TOPIC); POLYMERASE CHAIN REACTION; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADENOCARCINOMA; ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLINICAL TRIALS, PHASE III AS TOPIC; COITUS; COLOMBIA; FEMALE; FINLAND; HUMANS; MENARCHE; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT; SEXUAL BEHAVIOR; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84870209754     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis612     Document Type: Article

References (27)

1. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9. (Pubitemid 29406813)
2. Clifford GM, Smith JS, Plummer M, Münoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: A metaanalysis. Br J Cancer 2003; 88:63-73.
3. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102:3-8. (Pubitemid 127695953)
4. Stanley M. Pathology and epidemiology of HPV infection in females. Gynecologic Oncology 2010; 117:S5-10.
5. Plummer M, Peto J, Franceschi S. Time since first sexual intercourse and the risk of cervical cancer. Int J Cancer 2012; 130(11):2638-44.
6. Kapeu AS, Luostarinen T, Jellum E, et al. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks. Am J Epidemiol 2009; 169:480-8.
7. Lehtinen M, Ault KA, Lyytikainen E, et al. Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect 2011; 87:372-6.
8. Shew ML, Fortenberry JD, Miles P, Amortegui AJ. Interval between menarche and first sexual intercourse, related to risk of human papillomavirus infection. J Pediatr 1994; 125:661-6. (Pubitemid 2154920)
9. Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD. The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women. J Pediatr 2002; 141:718-23. (Pubitemid 35292775)
10. Collins SI, Mazloomzadeh S, Winter H, et al. Proximity of first intercourse to menarche and the risk of human papillomavirus infection: A longitudinal study. Int J Cancer 2005; 114:498-500. (Pubitemid 40279976)
11. Syrjanen K, Shabalova I, Petrovichev N, et al. Age at menarche is not an independent risk factor for high-risk human papillomavirus infections and cervical intraepithelial neoplasia. Int J STD AIDS 2008; 19:16-25. (Pubitemid 351738837)
12. Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356:1928-43. (Pubitemid 46740303)
13. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356:1915-27.
14. Henry MR. The Bethesda system 2001: An update of new terminology for gynecologic cytology. Clin Lab Med 2003; 23:585-603. (Pubitemid 37175546)
15. International patent numbers WO 2003/019143 A2, WO 2006/116276 A2, and WO 2006/116303 A2. 2008.http://wwwwipo.int/portal/index.html.en. Accessed 21 February 2011.
16. Villa LL, Costa RLR, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6:271-8. (Pubitemid 40590263)
17. Mao C, Koutsky LA, Ault KA, et al. Efficacy of human papillomavirus- 16 vaccine to prevent cervical intraepithelial neoplasia: A randomized controlled trial. Obstet Gynecol 2006; 107:18-27.
18. Dias D, Van Doren J, Schlottmann S, et al. Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomavirus 6, 11, 16 and 18. Clin Diagn Lab Immunol 2005; 12:959-69.
19. Agresti A. Categorical data analysis. New York: John Wiley & Sons, Inc., 1990.
20. Opalka D, Lachman CE, MacMullen SA, et al. Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16 and 18 by a multiplexed luminex assay. Clin Diagn Lab Immunol 2003; 10:108-15. (Pubitemid 36133838)
21. Palker TJ, Monteiro JM, Martin MM, et al. Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles. Vaccine 2001; 19: 3733-43. (Pubitemid 32522772)
22. Russell SL, Katz RV, Kressin NR, et al. Beliefs of women's risk as research subjects: A four-city study examining differences by sex and by race/ethnicity. J Womens Health (Larchmt) 2009; 18:235-43.
23. Toon PG, Arrand JR, Wilson LP, Sharp DS. Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia. Br Med J (Clin Res Ed) 1986; 293:1261-4. (Pubitemid 17181814)
24. Rocha-Zavaleta L, Yescas G, Cruz RM, Cruz-Talonia F. Human papillomavirus infection and cervical ectopy. Int J Gynaecol Obstet 2004; 85:259-66. (Pubitemid 38622557)
25. Castle PE, Jeronimo J, Schiffman M, et al. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res 2006; 66:1218-24. (Pubitemid 43165993)
26. Moscicki AB, Winkler B, Irwin CE Jr, Schachter J. Differences in biologic maturation, sexual behavior, and sexually transmitted disease between adolescents with and without cervical intraepithelial neoplasia. J Pediatr 1989; 115:487-93. (Pubitemid 19223197)
27. Moscicki AB, Burt VG, Kanowitz S, Darragh T, Shiboski S. The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women. Cancer 1999; 85: 1139-44. (Pubitemid 29115594)